EXETER, N.H.--(BUSINESS WIRE)--Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the three and six months ended June 30, 2007. Bentley’s consolidated revenues increased 8% to $31.2 million from $29.0 million reported in the second quarter of 2006. Bentley’s results in the second quarter of 2007 reflect the impact of a full quarter of reduced selling prices on the Company’s Spanish pharmaceutical products. Price reductions were implemented by the Spanish government on March 1, 2007. Increased unit volume has offset the impact of the price reductions on revenues. Revenues remained consistent with the comparable quarter of the prior year when expressed in constant currency.
